May 13, 2026
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today an update related to: Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG(TM) Catheter.
